
Remedent, Inc.
Aktie · US75954T1043 (OTC)
Kein Kurs
Schlusskurs OTC 03.11.2025:
0,0003 USD
03.11.2025 21:00
Aktuelle Kurse von Remedent, Inc.
| Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung |
|---|---|---|---|---|---|
UTC |
REMI
|
USD
|
03.11.2025 21:00
|
0,0003 USD
| 0,0001 USD
+50,00 %
|
Firmenprofil zu Remedent, Inc. Aktie
Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. It also provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. In addition, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice, which enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Further, it provides dental implant solutions and treatment concepts. The company sells its products to dental professionals in approximately 30 countries, including Asia, Europe, the Middle East, Canada, and the United States through its internal sales force and third party distributors. The company was founded in 1986 and is headquartered in Ghent, Belgium.
Unternehmensdaten
Name Remedent, Inc.
Firma Remedent, Inc.
Website
https://www.remedent.com
Heimatbörse
UTC
ISIN US75954T1043
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Instruments & Supplies
CEO Guy De Vreese
Land Belgien
Währung USD
Mitarbeiter 0,0 T
Adresse Zuiderlaan 1-3, 9000 Gent
IPO Datum 2006-03-01
Ticker Symbole
| Name | Symbol |
|---|---|
| Over The Counter | REMI |
Weitere Aktien
Investoren, die Remedent, Inc. halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.


